These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36525084)

  • 1. Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis.
    Radlinger B; Ress C; Folie S; Salzmann K; Lechuga A; Weiss B; Salvenmoser W; Graber M; Hirsch J; Holfeld J; Kremser C; Moser P; Staudacher G; Jelenik T; Roden M; Tilg H; Kaser S
    Diabetologia; 2023 Apr; 66(4):754-767. PubMed ID: 36525084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restricted feeding for 9h in the active period partially abrogates the detrimental metabolic effects of a Western diet with liquid sugar consumption in mice.
    Woodie LN; Luo Y; Wayne MJ; Graff EC; Ahmed B; O'Neill AM; Greene MW
    Metabolism; 2018 May; 82():1-13. PubMed ID: 29253490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
    Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
    EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
    Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
    J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
    Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
    Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.
    Xu L; Nagata N; Chen G; Nagashimada M; Zhuge F; Ni Y; Sakai Y; Kaneko S; Ota T
    BMJ Open Diabetes Res Care; 2019; 7(1):e000783. PubMed ID: 31749970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH.
    Perakakis N; Chrysafi P; Feigh M; Veidal SS; Mantzoros CS
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34199317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mineralocorticoid receptors in diet-induced hepatic steatosis and insulin resistance.
    Habibi J; Chen D; Hulse JL; Whaley-Connell A; Sowers JR; Jia G
    Am J Physiol Regul Integr Comp Physiol; 2022 Mar; 322(3):R253-R262. PubMed ID: 35107025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE
    Han JH; Oh TJ; Lee G; Maeng HJ; Lee DH; Kim KM; Choi SH; Jang HC; Lee HS; Park KS; Kim YB; Lim S
    Diabetologia; 2017 Feb; 60(2):364-376. PubMed ID: 27866224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
    Vatner DF; Goedeke L; Camporez JG; Lyu K; Nasiri AR; Zhang D; Bhanot S; Murray SF; Still CD; Gerhard GS; Shulman GI; Samuel VT
    Diabetologia; 2018 Jun; 61(6):1435-1446. PubMed ID: 29497783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.
    Wang D; Luo Y; Wang X; Orlicky DJ; Myakala K; Yang P; Levi M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
    Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
    Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Punicalagin Prevents Hepatic Steatosis through Improving Lipid Homeostasis and Inflammation in Liver and Adipose Tissue and Modulating Gut Microbiota in Western Diet-Fed Mice.
    Liu H; Zhan Q; Miao X; Xia X; Yang G; Peng X; Yan C
    Mol Nutr Food Res; 2021 Feb; 65(4):e2001031. PubMed ID: 33369197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.
    Aroor AR; Habibi J; Ford DA; Nistala R; Lastra G; Manrique C; Dunham MM; Ford KD; Thyfault JP; Parks EJ; Sowers JR; Rector RS
    Diabetes; 2015 Jun; 64(6):1988-2001. PubMed ID: 25605806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal jejunal bypass attenuates non-alcoholic fatty liver disease in western diet-obese rats.
    Ebertz CE; Bonfleur ML; Bertasso IM; Mendes MC; Lubaczeuski C; Araujo AC; Paes AM; de Amorim EM; Balbo SL
    Acta Cir Bras; 2014 Sep; 29(9):609-14. PubMed ID: 25252208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice.
    Merry TL; Tran M; Dodd GT; Mangiafico SP; Wiede F; Kaur S; McLean CL; Andrikopoulos S; Tiganis T
    Diabetologia; 2016 Dec; 59(12):2632-2644. PubMed ID: 27628106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
    PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
    Santos IB; de Bem GF; Cordeiro VSC; da Costa CA; de Carvalho LCRM; da Rocha APM; da Costa GF; Ognibene DT; de Moura RS; Resende AC
    Nutr Res; 2017 Jul; 43():69-81. PubMed ID: 28739056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.